IP Library Granted Patent US 12,121,728
Granted Patent B2
US 12,121,728 · App. 18/333,486 · Granted Oct 22, 2024

Systems and methods for enhancing function of spine stabilization muscles associated with a spine surgery intervention

Inventors: Dan Sachs (Minneapolis, MN); Prashant Brijmohansingh Rawat (Blaine, MN); Peter Andrew Crosby (Blaine, MN); Jason Hannon (Dublin, IE)
Assignee: Mainstay Medical Limited
A61N1/36067A61N1/0551A61N1/36071A61N1/36146A61N1/36167A61N1/37229A61N2/008A61N2/02A61N1/0558A61N1/36003A61N1/36125A61N1/36157A61N1/36175A61N1/36185A61N1/37247A61N2/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,121,728
App. No.
18/333,486
Granted
Oct 22, 2024
Kind
B2
Abstract

Systems and methods for enhancing muscle function of skeletal muscles in connection with a planned spine surgery intervention in a patient's back are provided. The method includes implanting one or more electrodes in or adjacent to tissue associated with one or more skeletal muscles within a back of a patient, the one or more electrodes in electrical communication with a pulse generator programmed for enhancing muscle function of the one or more skeletal muscles. Electrical stimulation is delivered, according to the programming during a time period associated with the planned spine surgery intervention, from the pulse generator to the tissue associated with the one or more skeletal muscles via the one or more electrodes, thereby improving neuromuscular control system performance of the one or more spine stabilizing muscles in connection with the planned spine surgery intervention to reduce the patient's recovery time associated with the planned spine surgery intervention.

Claims (36)

1. A system for treating a patient's back pain, the system comprising:

a first percutaneous lead comprising a first implantable electrode and a second percutaneous lead comprising a second implantable electrode, the first and second implantable electrodes configured to be positioned within the patient to deliver bilateral electrical stimulation to tissue associated with one or more spine stabilizing muscles associated with local segmental control of a lumbar spine within the patient's back; and

an external stimulator in electrical communication with the first and second implantable electrodes via the first and second percutaneous leads, respectively, the external stimulator configured to be programmed to cause delivery of the electrical stimulation to the tissue via the first implantable electrode to cause contraction of the one or more spine stabilizing muscles to improve neuromuscular control system performance associated with the one or more spine stabilizing muscles and via the second implantable electrode to reduce pain, thereby reducing the patient's back pain.

2. The system of claim 1 , wherein the first and second implantable electrodes are configured to be positioned within the patient to deliver the electrical stimulation to nervous tissue associated with a multifidus muscle.

3. The system of claim 2 , wherein the first implantable electrode is configured to be positioned within the patient to deliver the electrical stimulation to a medial branch of a dorsal ramus nerve innervating the multifidus muscle.

4. The system of claim 3 , wherein the external stimulator is configured to be programmed to cause delivery of the electrical stimulation to the medial branch of the dorsal ramus nerve via the first implantable electrode to cause the multifidus muscle to contract.

5. The system of claim 4 , wherein the multifidus muscle contraction caused by the electrical stimulation over time facilitates the improvement of neuromuscular control system performance.

6. The system of claim 1 , wherein the external stimulator is configured to be programmed to cause delivery of the electrical stimulation at a frequency selected from 1-30 Hz.

7. The system of claim 1 , wherein the external stimulator is configured to be programmed to cause delivery of the electrical stimulation at a frequency selected from 12-30 Hz.

8. The system of claim 1 , wherein the external stimulator is configured to be programmed to cause delivery of the electrical stimulation at an amplitude selected from less than 50 mA.

9. The system of claim 1 , wherein the first implantable electrode is configured to be positioned to deliver electrical stimulation to a medial branch of a dorsal ramus nerve that exits between L2 and L3 lumbar segments.

10. The system of claim 1 , wherein the neuromuscular control system performance is improved to restore function of the one or more spine stabilizing muscles to facilitate rehabilitation.

11. The system of claim 1 , further comprising one or more additional implantable electrodes.

12. The system of claim 1 , wherein the first percutaneous lead includes an anchor at a distal end of the first percutaneous lead.

13. The system of claim 12 , wherein the anchor is configured to be angled relative to the first percutaneous lead when implanted to anchor the first percutaneous lead in place.

14. The system of claim 1 , wherein the external stimulator is configured to be disposed external to the patient's body on a temporary basis.

15. The system of claim 1 , wherein the external stimulator is configured to be wirelessly coupled to the first and second implantable electrodes.

16. The system of claim 1 , wherein the external stimulator is programmed to deliver the electrical stimulation to the tissue adjunctive to a spine surgery intervention.

17. The system of claim 1 , wherein the external stimulator is programmed to deliver the electrical stimulation to the tissue before a spine surgery intervention.

18. The system of claim 1 , wherein the external stimulator is programmed to deliver the electrical stimulation to the tissue after a spine surgery intervention.

19. A system for treating a patient's back pain, the system comprising:

a first percutaneous lead comprising a first electrode and a second percutaneous lead comprising a second electrode, the first and second electrodes configured to be positioned within the patient to deliver bilateral electrical stimulation to tissue associated with a multifidus muscle which is associated with local segmental control of a lumbar spine within the patient's back; and

an external stimulator configured to be programmed to cause delivery of the electrical stimulation to the tissue associated with the multifidus muscle via the first electrode to cause the multifidus muscle to contract to improve neuromuscular control system performance associated with the multifidus muscle and via the second electrode to reduce pain, thereby reducing the patient's back pain.

20. The system of claim 19 , wherein the first and second electrodes are configured to be positioned within the patient to deliver the electrical stimulation to nervous tissue associated with the multifidus muscle.

21. The system of claim 20 , wherein the first electrode is configured to be positioned within the patient to deliver the electrical stimulation to a medial branch of a dorsal ramus nerve innervating the multifidus muscle.

22. The system of claim 19 , wherein the multifidus muscle contraction caused by the electrical stimulation over time facilitates the improvement of neuromuscular control system performance.

23. The system of claim 19 , wherein the external stimulator is configured to be programmed to cause delivery of the electrical stimulation at a frequency selected from 12-30 Hz.

24. The system of claim 19 , wherein the neuromuscular control system performance is improved to restore function of the multifidus muscle.

25. The system of claim 19 , wherein the first percutaneous lead comprises an anchor at a distal end of the first percutaneous lead.

26. The system of claim 25 , wherein the anchor is configured to be angled relative to the first percutaneous lead when implanted to anchor the first percutaneous lead in place.

27. The system of claim 19 , wherein the first percutaneous lead further comprises one or more additional electrodes.

28. The system of claim 19 , wherein the external stimulator is configured to be disposed external to the patient's body on a temporary basis.

29. A system for treating a patient's back pain, the system comprising:

first and second electrodes on first and second leads, respectively, the first and second electrodes configured to be positioned within the patient to deliver bilateral electrical stimulation to a medial branch of a dorsal ramus nerve innervating a multifidus muscle which is associated with local segmental control of a lumbar spine within the patient's back; and

an external stimulator configured to be programmed to cause delivery of the electrical stimulation to the medial branch of the dorsal ramus nerve innervating the multifidus muscle via the first electrode to cause contraction and restore neural drive of the multifidus muscle and via the second electrode to reduce pain, thereby reducing the patient's back pain.

30. The system of claim 29 , wherein the multifidus muscle contraction caused by the electrical stimulation over time facilitates the improvement of neuromuscular control system performance.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2023
From: SACHS, DAN; RAWAT, PRASHANT BRIJMOHANSINGH; CROSBY, PETER ANDREW; HANNON, JASON
To: MAINSTAY MEDICAL LIMITED
Reel/Frame 063940/0595 →
Continuity (19)
Continuation 17660375 · Apr 22, 2022
Continuation 17411713 · Aug 25, 2021
Continuation 17173121 · Feb 10, 2021
Continuation 16817574 · Mar 12, 2020
Continuation 16264632 · Jan 31, 2019
Continuation In Part 15944730 · Apr 3, 2018
Continuation 15853543 · Dec 22, 2017
Continuation 15299399 · Oct 20, 2016
Continuation 14849478 · Sep 9, 2015
Continuation 14792430 · Jul 6, 2015
Continuation 14061614 · Oct 23, 2013
Continuation In Part 13858809 · Apr 8, 2013
Continuation In Part 13045435 · Mar 10, 2011
Continuation 13045421 · Mar 10, 2011
Continuation 12075174 · Mar 10, 2008
Provisional Application 61339957 · Mar 11, 2010
Provisional Application 61339943 · Mar 11, 2010
Provisional Application 60905979 · Mar 9, 2007
Related Publication 20230321438A1 · Oct 12, 2023
Cited By (5)
US 12,285,612 US 12,458,802 US 12,582,816 US 12,594,096 US 12,702,824